IKZF1 and acute lymphoblastic leukemia: While PAX5-altered ALL has not been well connected to RARA nuclear receptor signaling, there has been previous work treating IKZF1-mutated BCR-ABL1 ALL with RARA and RXR agonists that suppressed a self-renewal phenotype.49